Biomedicines

Biomedicines is an international, peer-reviewed, open access journal on biomedicines published monthly online by MDPI. The Society for Regenerative Medicine (Russian Federation) (RPO) is affiliated with Biomedicines and its members receive discounts on the article processing charges.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, CAPlus / SciFinder, and other databases.
  • Journal Rank: JCR - Q1 (Pharmacology & Pharmacy) / CiteScore - Q2 (Medicine (miscellaneous))
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 15.4 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the second half of 2023).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
  • Companion journals for Biomedicines include: IJTMBioMed, Anesthesia Research and Emergency Care and Medicine.
 
Impact Factor: 4.7 (2022); 5-Year Impact Factor: 4.9 (2022)
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Biomedicines, BioMedInformatics, Cancers, JCM, Cells, Current Oncology
Cancer Immunity and Immunotherapy: Early Detection, Diagnosis, Systemic Treatments, Novel Biomarkers, and Resistance Mechanisms Topic Editors: Tao Jiang, Yongchang Zhang??
Deadline: 20 April 2024
Topic in Biomedicines, Cancers, JFB, Nanomaterials, Polymers
Advanced Functional Materials for Regenerative Medicine Topic Editors: Antonino Morabito, Luca Valentini
Deadline: 6 June 2024
Topic in Biomedicines, Current Oncology, Diagnostics, Gastrointestinal Disorders, JCM
Advances in Gastrointestinal and Liver Disease: From Physiological Mechanisms to Clinical Practice Topic Editors: Davide Giuseppe Ribaldone, Gian Paolo Caviglia
Deadline: 20 June 2024
Topic in BioChem, Biomedicines, Biomolecules, IJMS, Metabolites, Molecules
Natural Products in Prevention and Therapy of Metabolic Syndrome Topic Editors: Jianbo Wan, Ligen Lin
Deadline: 30 June 2024
Special Issue in Biomedicines
Vascular Embolization: Present and Future Guest Editor: Romaric Loffroy
Deadline: 30 April 2024
Special Issue in Biomedicines
The IGF2-Regulated Cellular- and Genetic Network in Physiology and Disease: A Call to Action Guest Editor: Pierluigi Scalia
Deadline: 15 May 2024
Special Issue in Biomedicines
Advances in Therapeutic Strategies in Gynecological Malignant Tumors Guest Editor: Alberto Farolfi
Deadline: 31 May 2024
Special Issue in Biomedicines
Drugs Targeting the Disease Progression, Cognitive Impairment, Anxiety and Other Co-morbidities in Epilepsy: From Bench to Bedside Guest Editors: Diana Cunha-Reis, Paulo Correia-de-Sá
Deadline: 15 June 2024
Topical Collection in Biomedicines
OMICs and Complex Diseases Collection Editors: Mostafa Dianatinasab, Anke Wesselius, Amin Salehi-Abargouei
Topical Collection in Biomedicines
Feature Papers in Cancer Biology and Therapeutics Collection Editor: Veronique Baud
Topical Collection in Biomedicines
Feature Papers in Gene and Cell Therapy Collection Editor: Bernard Lebleu
Topical Collection in Biomedicines
Feature Papers in Microbiology in Human Health and Disease Collection Editor: Ryota Niikura
Back to TopTop
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news